Destination Wealth Management Oncocyte Corp Transaction History

Destination Wealth Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 19, 2019	SELL	$2.49 - $5.45 $73,843 - $161,625	-29,656 Closed	0 $0
Q3 2018 Nov 07, 2018	BUY	$2.2 - $3.45 $65,243 - $102,313	29,656 New	29,656 $74,000
Q2 2018 Jul 31, 2018	SELL	$2.0 - $3.3 $59,312 - $97,864	-29,656 Closed	0 $0
Q2 2017 Aug 11, 2017	BUY	N/A	29,656	29,656 $154,000

399K

Ticker OCX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,609,000
Market Cap $238M
Description
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....

Get notified when there are updates to the investment portfolio of Destination Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Destination Wealth Management with notifications on news.